Data_Sheet_1_MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3.zip
MicroRNAs have been implicated in acting as oncogenes or anti-oncogenes in breast cancer by regulating diverse cellular pathways. In the present study, we investigated the effects of miR-99a on cell biological processes in breast cancer. Breast cancer cells were transfected with a lentivirus that expressed miR-99a or a scramble control sequence. Functional experiments showed that miR-99a reduced breast cancer cell proliferation, invasion and migration. Tumor xenograft experiment suggested miR-99a overexpression inhibited breast cancer cell proliferation in vivo. The dual luciferase assay revealed that miR-99a directly targets FGFR3 by binding its 3′ UTR in breast cancer. miR-99a was strongly down-regulated in breast tumor and FGFR3 was significantly up-regulated in breast tumor. FGFR3 silencing inhibited proliferation, migration and invasion of breast cancer cells. Deep sequencing indicated that miR-99a overexpression regulates multiple signaling pathways and triggers the alteration of the whole transcriptome. We constructed correlated expression networks based on circRNA/miRNA and lncRNA/miRNA competing endogenous RNAs regulation and miRNA-mRNA interaction, which provided new insights into the regulatory mechanism of miR-99a. In conclusion, these results suggest that the miR-99a/FGFR3 axis is an important tumor regulator in breast cancer and might have potential as a therapeutic target.
History
References
- https://doi.org//10.1016/S0092-8674(04)00045-5
- https://doi.org//10.1016/j.tcb.2014.11.004
- https://doi.org//10.1038/msb4100089
- https://doi.org//10.1038/nature03076
- https://doi.org//10.1016/S0092-8674(03)00231-9
- https://doi.org//10.2353/ajpath.2010.090664
- https://doi.org//10.1038/nature03702
- https://doi.org//10.3322/caac.21262
- https://doi.org//10.1007/s12282-017-0814-8
- https://doi.org//10.1038/leu.2011.299
- https://doi.org//10.4149/neo_2016_518
- https://doi.org//10.1038/onc.2013.77
- https://doi.org//10.1002/jcb.24965
- https://doi.org//10.18632/oncotarget.5355
- https://doi.org//10.1371/journal.pone.0092099
- https://doi.org//10.14806/ej.17.1.200
- https://doi.org//10.1038/nmeth.1923
- https://doi.org//10.1186/gb-2013-14-4-r36
- https://doi.org//10.1038/nbt.3122
- https://doi.org//10.1096/fj.12-214692
- https://doi.org//10.1007/s10549-009-0674-9
- https://doi.org//10.1002/pmic.201400515
- https://doi.org//10.1101/gad.974702
- https://doi.org//10.1093/bioinformatics/btx627
- https://doi.org//10.1111/cpr.12146
- https://doi.org//10.4238/gmr.15038338
- https://doi.org//10.1158/0008-5472.CAN-09-0744
- https://doi.org//10.1038/12615
- https://doi.org//10.4149/neo_2016_405
- https://doi.org//10.1073/pnas.111114298
- https://doi.org//10.1016/j.ccr.2007.08.003
- https://doi.org//10.1002/ijc.26304
- https://doi.org//10.1177/1947601912449832
- https://doi.org//10.1158/1541-7786.MCR-09-0189
- https://doi.org//10.1007/s10549-009-0362-9
- https://doi.org//10.1016/j.lfs.2016.02.059
- https://doi.org//10.1155/2015/207684
- https://doi.org//10.1371/journal.pone.0020980
- https://doi.org//10.2147/OTT.S110969
- https://doi.org//10.18632/oncotarget.7828
- https://doi.org//10.1186/s12943-017-0696-6